Great to see the launch of this new #Encephalitis learning collection on BMJ Learning, designed to support doctors, trainees and the wider healthcare workforce with practical, evidence-based education.
Well done to everyone involved!
www.encephalitis.info/global-training-modules-on-encephalitis/
Posts by Meera Chand
A screenshot of the new Pathoplexus homepage showing all viruses now supported, including Dengue and Yellow Fever, which are circled in red
1/ 🦟 Big news: #Pathoplexus now supports Dengue virus & Yellow Fever virus - two arboviruses responsible for over 400 million infections and up to 94,000 deaths per year.
Here's what’s new in our latest update 👇🏻
Read the full update: pathoplexus.org/news/2026-03... 📰
If you want to join a team making pathogen sequencing and analysis for public health, surveillance, and research more accessible, more equitable and more ✨awesome✨ - look no further - come join us on this mission at ARTIC!
#openscience #opendata #opensource
We are recruiting for a number of PhDs in the HPRU in Public Health Genomics, based at @unibirmingham.bsky.social, in collaboration with UKHSA. 🦠🧬
Apply below to work on cutting-edge science and public health priorities! (NB deadline of 9th January / UK only due to funding restrictions)
(1/7)
Got a number in mind?
A new pre-print by @lshtm.bsky.social colleagues surveyed 13,000 participants, and found it's about 9 per day in the current era.
It also looks at how social mixing varies with age, ethnicity and social economic status. Link to paper:
A figure showing the primary efficacy analyses in the trial populations.
Data on treatments for bubonic plague are limited. In this open-label, randomized, controlled trial in Madagascar, ciprofloxacin monotherapy was noninferior to a standard aminoglycoside–ciprofloxacin regimen. Full IMASOY trial results: nej.md/3Ugs0kx
#MedSky #IDSky
Early notice of NEW Wellcome Conference -
AIR 2026: Genomic and Systems Approaches to Respiratory Infection, Microbiomes and Immunity 11th-13th February, sign up below for notifications
coursesandconferences.wellcomeconnectingscience.org/our-events/c...
It's immunulogy AND it's microbiology 🫁
Some great new features and updates from the awesome Pathoplexus project. This is a new open pathogen genome database that can provide access to your sequences under a use-restricted license but also feed directly in to INSDC (EBI, Genbank etc) when you are ready. pathoplexus.org/news/2025-07...
🔗 Read more: bit.ly/4esZ0zr
▶️ Watch the explainer animation: youtu.be/DDNTOB8EsF8
#ECDC #GlobalHealth #HealthSecurity #Epidemiology #IDsky #EpiSky #Dengue #Chikungunya #Zika
📢 @who.int Risk evaluation of #Oropouche #virus and its reassortants 🪰 🦟
www.who.int/publications...
A new report describes the genetic epidemiology and antimicrobial-resistance patterns of a surge of cases of 𝘊𝘰𝘳𝘺𝘯𝘦𝘣𝘢𝘤𝘵𝘦𝘳𝘪𝘶𝘮 𝘥𝘪𝘱𝘩𝘵𝘩𝘦𝘳𝘪𝘢𝘦 infection that was identified in migrant populations in Europe. Read the full report: nej.md/3HEF3ZS
#MedSky #IDSky
Rolling clinical and epi updates for #mpox data from #SierraLeone. Watch for updated versions as additional data becomes available. Heartfelt thanks to our local colleagues in-country led by Dr. Jia Kangbai
t.co/D9QosVP1Bq
Interested in pneumococci, genomics and metagenomics? Come and do a PhD with me, @alanmcn1.bsky.social and @meerac.bsky.social @ukhsa.bsky.social www.findaphd.com/phds/project...
Amazing work from our colleagues in Sierra Leone, Nigeria, and elsewhere, making the first sequences available from the ongoing Mpox epidemic in Sierra Leone.
More to come - for now, head over to @pathoplexus.org:
pathoplexus.org/seqsets/PP_S...
A long thread about mpox and the context specific nature of outbreaks prompted by the large outbreak of MPXV Clade IIb happening at the moment in Sierra Leone:
Super exciting that we're now up to eight viruses supported on Pathoplexus - with lots of other exciting features in the pipeline too!
Absolutely thrilled to announce the launch of ARTIC2 - a £5.5M 5 year project funded by @wellcometrust.bsky.social to build on the ARTIC approach of low-cost, globally accessible genome sequencing for surveillance of outbreaks, epidemics and endemic diseases: www.birmingham.ac.uk/news/2025/am...
Image showing the table of content of issue 15 in 2025 featuring the following articles: Surveillance Increased incidence of human leptospirosis and the effect of temperature and precipitation, the Netherlands, 2005 to 2023 Description and comparison of national surveillance systems and response measures for Aedes-borne diseases in France, Italy and Portugal: a benchmarking study, 2023 Research Seroprevalence of West Nile virus, Greece, 2020 Prevalence and risk factors for carriage of carbapenem-resistant Acinetobacter baumannii in post-acute care hospitals, Israel, 2021 Letter Letter to the editor: Statistical methodology critique and alternative approaches in H5Nx avian influenza seroprevalence study among French cats Authors’ response: Statistical methodology critique and alternative approaches in H5Nx avian influenza seroprevalence study among French cats
Check out our new issue with a study describing and comparing 🦟 Aedes-borne disease (#dengue #chikungunya and #Zika) incidence from 2017-2023, and the surveillance systems and response measures operating in France, Italy and Portugal in 2023
🗞️ bit.ly/EUS3015
#IDSky #EpiSky #MedSky #PublicHealth 🦠
Mpox Clade I emerged in 2023 in South Kivu and since has spread sustained through direct human to human contact. Controlling this outbreak has turned out to be a major challenge. Through embedded outbreak research coupled with a local capacity building program, we first....
Dr Esther Robinson, Head of the TB Unit at UKHSA, said: "TB is curable and preventable, but the disease remains a serious public health issue in England. While England is still considered a low-incidence country for TB, the rise in cases over recent years means that we are now just below that threshold. This call for evidence will help us develop an action plan that prioritises the most effective interventions to reverse this trend, focusing particularly on the needs of those most affected."
We need the help of academics, health & policy professionals, and people with lived experience of tuberculosis (TB) to shape our next TB Action Plan. Together we can improve how we prevent, detect, and control TB. 🛡️
🗓️ Deadline: 2 May
🔗 www.gov.uk/government/n...
Another arbovirus popping up in our enhanced surveillance pubmed.ncbi.nlm.nih.gov/40133068/ Not too surprising but a first for our country. No human disease noted, but first indication that we may need to start considering it. First step is to understand if this is a one off finding or not
Today we have published our first annual report on infectious disease trends. 📊
The report brings together all the key data from 2023 to early 2025 and outlines the steps our organisation is taking to tackle these threats.
Read the full report 🔗🔽
www.gov.uk/government/p...
In study led by @csimonich.bsky.social & Teagan McMahon, we quantify antigenic evolution of RSV F
Important because:
1️⃣ RSV top cause of infant hospitalization in USA
2️⃣ New antibodies & vax can prevent hospitalizations
3️⃣ Will virus evolution erode their efficacy?
www.biorxiv.org/content/10.1...
Our analysis of the second incursion of H5N1 viruses (genotype D1.1) into dairy cattle in the US is now posted to virological virological.org/t/timing-and...
Neuraminidase reassortment and oseltamivir resistance in clade 2.3.4.4b A(H5N1) viruses circulating among Canadian poultry, 2024
www.tandfonline.com/doi/full/10....
Core-funded postdoc position at The Pirbright Institute, Surrey, UK (just outside London), in the group of Professor Ian Brown.
Working on H5N1 avian influenza virus evolution and development of cross-reactive vaccines.
www.pirbright.ac.uk/careers-and-...
First genome sequence from the Ugandan Ebolavirus outbreak with analysis: virological.org/t/990 and first filovirus genome submitted to Pathoplexus database: pathoplexus.org/seq/PP_0011C.... Great (and rapid) work from the National Health Laboratory, UVRI and partners.
Great to be able to share this today - looking forward to working with partners all over the country for the next phase